Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Decomplix is a Swiss medtech regulatory and quality consultancy focused on helping medical device and in-vitro diagnostic companies obtain and maintain market access. The company provides CE marking support, regulatory strategy, quality management assistance, Swiss importer compliance support, and Swiss Authorised Representative (CH-REP) services. It also supports software as a medical device programs, including a partnered pathway to CE-certified medical device software. Decomplix appears to operate as a boutique, service-based company rather than a therapeutic product developer, serving startups through larger corporates that need help navigating EU and Swiss medical device requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Decomplix.